Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Avigra |
Active Ingredient: | Sildenafil citrate 35.112mg equivalent to sildenafil 25mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Product: | Avigra |
Active Ingredient: | Sildenafil citrate 70.225mg equivalent to sildenafil 50mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Product: | Avigra |
Active Ingredient: | Sildenafil citrate 140.45mg equivalent to sildenafil 100mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Product: | Noradrenaline |
Active Ingredient: | Noradrenaline acid tartrate monohydrate 0.12mg/mL equivalent to noradrenaline base 0.06mg/mL |
Dosage Form: | Solution for infusion |
New Zealand Sponsor: | Biomed Limited |
Manufacturer: | Biomed Limited, Auckland, New Zealand |
Product: | Viagra |
Active Ingredient: | Sildenafil citrate 35.112mg equivalent to sildenafil 25mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Product: | Viagra |
Active Ingredient: | Sildenafil citrate 70.225mg equivalent to sildenafil 50mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Product: | Viagra |
Active Ingredient: | Sildenafil citrate 140.45mg equivalent to sildenafil 100mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Upjohn New Zealand ULC |
Manufacturer: | Fareva Amboise, Poce Sur Cisse, France |
Dated this 13th day of October 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).